SCHEMBL490681

SCHEMBL490681

CC(C(=O)O)c1cccc(O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 9/20 0.61
PTGS2 P35354 8/20 0.61
MAPT P10636 3/20 0.61
LMNA P02545 3/20 0.61
HIF1A Q16665 3/20 0.61
SLC22A6 Q4U2R8 3/20 0.61
CXCR1 P25024 2/20 0.61
CXCR2 P25025 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
KDM4E B2RXH2 2/20 0.61
CYP3A4 P08684 2/20 0.61
HPGD P15428 2/20 0.61
RECQL P46063 1/20 0.61
ALDH1A1 P00352 1/20 0.61
MAPK1 P28482 1/20 0.61
PMP22 Q01453 1/20 0.61
HSD17B10 Q99714 1/20 0.61
CXCL8 P10145 1/20 0.61
THPO P40225 1/20 0.61
AKR1C3 P42330 5/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3858080 1.00 PTGS1 (0.61) PTGS1PTGS2MAPTLMNAHIF1A
Phosphoric Acid SCHEMBL27934163 0.93 AKR1C3 (0.55) PTGS1PTGS2MAPTLMNAHIF1A
SCHEMBL10794629 0.88 ADRB1 (0.52) PTGS1PTGS2MAPTLMNAHIF1A
SCHEMBL602096 0.87 PTGS2 (0.69) PTGS1PTGS2MAPTLMNAHIF1A
SCHEMBL11756863 0.86 ADRB1 (0.53) PTGS1PTGS2MAPTLMNAHIF1A
Phenol SCHEMBL27926442 0.83 PTGS2 (0.64) PTGS1PTGS2MAPTLMNAHIF1A
SCHEMBL21114393 0.83 AKR1C3 (0.47) PTGS1PTGS2MAPTLMNAHIF1A
Phenol SCHEMBL31015754 0.83 PTGS1 (0.55) PTGS1PTGS2MAPTLMNAHIF1A
SCHEMBL1617654 0.82 ADRB1 (0.55) PTGS1PTGS2MAPTLMNAHIF1A
SCHEMBL28428967 0.82 PTGS1 (0.54) PTGS1PTGS2MAPTLMNAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 372 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051551-A1 IMPROVED POLYMER COMPOSITES WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) 2025-02-13 US claimed
US-20240369563-A1 BIOMARKER COMBINATION FOR ASSESSING RISK OF ADENOMA AND COLORECTAL CANCER, AND USE THEREOF HUMAN METABOLOMICS INSTITUTE, INC. (CN) 2024-11-07 US claimed
WO-2024178621-A1 USE OF COMPOUNDS IN PREVENTING AND/OR TREATING OBESITY OR NAFLD Westlake University (CN) 2024-09-06 WO claimed
CN-117700334-A 3-hydroxy phenyl propionic acid derivative, 3-hydroxy phenyl propionic acid immunodetection reagent and preparation method thereof 合肥爱索特克医学检验实验室有限公司 2024-03-15 CN claimed
CN-116519827-A Method for inhibiting sesame pathogenic bacteria active ingredient generated by analyzing penicillium beijerinckii based on non-target metabonomics 河南省农业科学院植物保护研究所 2023-08-01 CN claimed
WO-2022242779-A1 BIOMARKER COMBINATION FOR ASSESSING RISK OF ADENOMA AND COLORECTAL CANCER, AND USE THEREOF 深圳市绘云生物科技有限公司 2022-11-24 WO claimed
CN-115372490-A Biomarker for assessing risk of adenoma and colorectal cancer and application thereof 深圳市绘云生物科技有限公司 2022-11-22 CN claimed
US-11390531-B2 Mesoporous silica film structure having ultra-large pore and method of manufacturing the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2022-07-19 US claimed
US-20210300770-A1 MESOPOROUS SILICA FILM STRUCTURE HAVING ULTRA-LARGE PORE AND METHOD OF MANUFACTURING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2021-09-30 US claimed
US-20170312270-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2017-11-02 US claimed
CN-103826633-A Methylphenidate prodrugs, methods of making and using the same KEMPHARM INC 2014-05-28 CN claimed
US-20130150395-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF KEMPHARM, INC. (US) 2013-06-13 US claimed
US-8404746-B2 Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2013-03-26 US claimed
WO-2013016668-A2 METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME KEMPHARM INC. (US) 2013-01-31 WO claimed
US-20120142720-A1 Phenylethanoic Acid, Phenylpropanoic Acid and Phenylpropenoic Acid Conjugates and Prodrugs of Hydrocodone, Methods of Making and Use Thereof KEMPHARM, INC. (US) 2012-06-07 US claimed
EP-2448408-A1 PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHODS OF MAKING AND USE THEREOF Kempharm, Inc. (US) 2012-05-09 EP claimed
US-20110015140-A1 ANTI-DIABETES COMPOSITION CONTAINING CHICORIC ACID AND/OR ONE OF THE METABOLITES THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) 2011-01-20 US claimed
WO-2011002995-A1 PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHODS OF MAKING AND USE THEREOF KEMPHARM, INC. (US) 2011-01-06 WO claimed
US-20110002991-A1 PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHOD OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2011-01-06 US claimed
US-7452938-B2 Aqueous resin composition, aqueous coating material containing the composition, coating provided by the material, and metal plate coated with the material TOYO BOSEKI KABUSHIKI KAISHA (JP) 2008-11-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142720-A1 Phenylethanoic Acid, Phenylpropanoic Acid and Phenylpropenoic Acid Conjugates and Prodrugs of Hydrocodone, Methods of Making and Use Thereof CYP7A1, CYP2B6, CYP2D6 PTGS1 154/4885PTGS2 389/4885MAPT 2125/4885
US-20170312270-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF OPRM1, OPRK1, OPRD1 PTGS1 55/4885PTGS2 119/4885MAPT 2959/4885
US-20110002991-A1 PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHOD OF MAKING AND USE THEREOF CYP7A1, CYP2B6, CYP2D6 PTGS1 157/4885PTGS2 393/4885MAPT 2161/4885
US-20110015140-A1 ANTI-DIABETES COMPOSITION CONTAINING CHICORIC ACID AND/OR ONE OF THE METABOLITES THEREOF IAPP, GPR119, HMGCR PTGS1 2811/4885PTGS2 4262/4885MAPT 1777/4885
US-20130150395-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF OPRM1, OPRK1, CYP2D6 PTGS1 617/4885PTGS2 850/4885MAPT 1933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.